HRs for SF1.8 (HR = 1.16, 0.99-1.36) and SF2.0 (HR = 1.06, 0.93-1.20) compared with HF1.5 in stage IIb-III patients did not reach statistical significance.
← all excerpts
The Role of Thoracic Radiation Therapy Dosing in the Treatment of Limited-Stage Small Cell Lung Cancer: A Study Based on the National Cancer Database.
1
—
—